Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

2.

[Complex of the herpes simplex virus initiator protein UL9 with DNA as a platform for the design of a new type of antiviral drugs].

Surovaia AN, Gorohovskiĭ SL, Gurskiĭ IaG, Andronova VL, Arkhipova VS, Bazhulina NP, Galegov GA, Gurskiĭ GV.

Biofizika. 2010 Mar-Apr;55(2):239-51. Russian.

PMID:
20429277
3.

Activation of the herpes simplex virus type-1 origin-binding protein (UL9) by heat shock proteins.

Tanguy Le Gac N, Boehmer PE.

J Biol Chem. 2002 Feb 15;277(7):5660-6. Epub 2001 Nov 15.

6.

Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs.

Bazhulina NP, Surovaya AN, Gursky YG, Andronova VL, Moiseeva ED, Nikitin CA, Golovkin MV, Galegov GА, Grokhovsky SL, Gursky GV.

J Biomol Struct Dyn. 2014;32(9):1456-73. doi: 10.1080/07391102.2013.820110. Epub 2013 Jul 24.

8.
11.
12.
13.
15.
16.

The neural F-box protein NFB42 mediates the nuclear export of the herpes simplex virus type 1 replication initiator protein (UL9 protein) after viral infection.

Eom CY, Heo WD, Craske ML, Meyer T, Lehman IR.

Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4036-40. Epub 2004 Mar 9.

17.

Interaction between the herpes simplex virus type 1 origin-binding and DNA polymerase accessory proteins.

Monahan SJ, Grinstead LA, Olivieri W, Parris DS.

Virology. 1998 Feb 1;241(1):122-30.

20.

Interaction of herpes simplex virus 1 origin-binding protein with DNA polymerase alpha.

Lee SS, Dong Q, Wang TS, Lehman IR.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7882-6.

Supplemental Content

Support Center